Seattle Genetics
Seagen (formerly Seattle Genetics) is a biotechnology company focused on developing and commercializing antibody-drug conjugate (ADC) therapies for the treatment of cancer. Founded in 1998 and headquartered in Bothell, Washington, Seagen leverages its proprietary technology platform to create targeted therapies that deliver cytotoxic agents directly to tumor cells while sparing healthy tissue. The company’s portfolio includes FDA‑approved products such as Tivdak, Padcev, and Enhertu, and it maintains a robust pipeline of investigational ADCs across multiple oncology indications. Seagen is publicly traded on NASDAQ under the ticker SGEN and is committed to advancing precision oncology through innovative research and strategic collaborations.
Seattle Genetics is profiled on the APIs.io network. Tagged areas include Biotechnology, Oncology, ADC, CancerTherapy, and Seattle.
Seattle Genetics’ developer surface includes documentation and 9 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Documentation 1
Reference material describing how the API behaves
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API
Other 3
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.